POST Online Media Lite Edition



 

Health : Page 6

New microbiome insights could help boost immunotherapy for range of rare cancers

March 1, 2024
The microbiome can identify those who benefit from combination immunotherapy across multiple different cancers, including rare gynecological cancers, biliary tract cancers and melanoma.

Vaping can increase susceptibility to infection by COVID-19

February 27, 2024
Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a study by a research team at University of California, Riverside, has found.

AstraZeneca's Voydeya treatment recommended for EU approval

February 26, 2024
AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

GSK gonorrhoea treatment achieves efficacy endpoint in latest trial

February 26, 2024
GSK PLC on Monday announced positive results from the latest trial of its oral gonorrhoea treatment, showing it to be on par with intramuscular therapies.

Secret, undeclared pesticide ingredients may pose risk to people, pollinators and environment

February 26, 2024
In a new article in Environmental Science and Policy authored by a researcher from Trinity, the case is made that secret ingredients in pesticides could be posing risks to people, pollinators and the environment.

Glucagon is key for kidney health

February 26, 2024
Glucagon, a hormone best known for promoting blood sugar production in the liver, also appears to play a key role in maintaining kidney health.

U.S. FDA warns using smartwatches to measure blood glucose

February 23, 2024
The US Food and Drug Administration (FDA) warned consumers of the risks related to using smartwatches or smart rings that measure blood glucose levels without piercing the skin.

Terahertz biosensor detects skin cancer with remarkable accuracy

February 21, 2024
Researchers have developed a revolutionary biosensor using terahertz (THz) waves that can detect skin cancer with exceptional sensitivity, potentially paving the way for earlier and easier diagnoses.

WuXi Advanced Therapies receives FDA approval to manufacture Iovance's AMTAGVI (lifileucel) for advanced melanoma

February 21, 2024
WuXi Advanced Therapies announced that the U.S. Food and Drug Administration (FDA) has approved its Philadelphia site to begin the analytical testing and manufacturing of AMTAGVI for Iovance, which received FDA accelerated approval of its Biologics License Application (BLA) on February 16, 2024.

Problems with sleep can trigger range of psychiatric disorders

February 20, 2024
Problems with sleep and internal body clock can trigger or worsen a range of psychiatric disorders, according to a new review of recent research evidence.

FDA approves Xolair as first and only medicine for children and adults with one or more food allergies

February 19, 2024
Roche announced that the U.S. Food and Drug Administration (FDA) has approved Xolair (omalizumab) for the reduction of allergic reactions, including anaphylaxis, that may occur with accidental exposure to one or more foods in adult and paediatric patients aged 1 year and older with IgE-mediated food allergy.

Record storms in California lead to surging deadly fungal infections

February 19, 2024
The recent \"atmospheric river\" storms in California are fueling public health concerns as cases of Valley Fever, a fungus induced disease, have surged following heavy rainfalls in the U.S. state.
<< 6 7 8 9 10 ... >>